The Julphar story is one of innovation and leadership. Since our journey began in 1980, our goal has remained the same – to bring better healthcare and a brighter future to families across the globe. And in less than 40 years, we have expanded our network across the Middle East and Africa to become one of the largest pharmaceutical manufacturers in the region.
Headquartered in Ras Al Khaimah in the United Arab Emirates, we employ 2,500 people worldwide, and we market our products in more than 50 countries. We have 13 internationally accredited facilities that produce more than half a million medicine boxes a day, including tablets, syrups, suspensions, creams and injectables, and vaccines.
Julphar has an extensive portfolio of generic medicines, branded generics, and over-the-counter medicines, as well as APIs (active pharmaceutical ingredients). We develop and manufacture medicines and supplements for everything from the common cold to diabetes.
pharmaceuticals, generics, manufacturing, insulin, biotechnology, biopharmaceuticals, diabetes, consumer care, pain management, otc, innovation, r, d, research, development, healthcare, uae, mea, middle east, pharma, pharmacological